Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-15-031578

← back to feed
Filed
May 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 11, 2015 20.41M sh
Shares Diluted Q1 2015 · Mar 31, 2015 20.41M sh
Shares Diluted Q1 2015 · Mar 31, 2014 20.37M sh
Capex Q1 2015 · Mar 31, 2015 $0
Capex Q1 2015 · Mar 31, 2014 $20.1K
Stockholders Equity Q1 2015 · Mar 31, 2015 −$3.01M
Stockholders Equity Q1 2015 · Dec 31, 2014 −$588.89K
Current Liabilities Q1 2015 · Mar 31, 2015 $1.92M
Current Liabilities Q1 2015 · Dec 31, 2014 $2.16M
Total Liabilities Q1 2015 · Mar 31, 2015 $8.16M
Total Liabilities Q1 2015 · Dec 31, 2014 $8.84M
Current Assets Q1 2015 · Mar 31, 2015 $5.11M
Current Assets Q1 2015 · Dec 31, 2014 $8.21M
Total Assets Q1 2015 · Mar 31, 2015 $5.14M
Total Assets Q1 2015 · Dec 31, 2014 $8.25M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $21.35M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $26.77M
Sga Expense Q1 2015 · Mar 31, 2014 $1.73M
Rd Expense Q1 2015 · Mar 31, 2014 $4.43M
Net Income Q1 2015 · Mar 31, 2014 −$446.44K
Operating Income Q1 2015 · Mar 31, 2014 −$6.16M